Pacira BioSciences, Inc. - Laporan Laba Rugi (TTM)

Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Pacira BioSciences, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 421 430 443 503 513 542 580 614 654 667 669 669 666 675 682 690 695 701 703 706
Change (%) 2.03 3.11 13.56 2.04 5.50 7.20 5.83 6.47 1.95 0.35 0.01 -0.53 1.40 1.00 1.25 0.67 0.86 0.26 0.44
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 178 177 178 190 192 196 206 235 259 284 277 267 273 261 244 256 221 252 239 236
Change (%) -0.52 0.95 6.67 0.83 2.03 5.34 14.10 10.14 9.61 -2.39 -3.56 2.15 -4.49 -6.49 4.72 -13.69 14.27 -5.03 -1.22
% of Revenue 42.19 41.14 40.28 37.83 37.39 36.16 35.53 38.31 39.63 42.60 41.44 39.96 41.04 38.66 35.79 37.01 31.73 35.95 34.06 33.49
Gross Operating Profit 243 253 265 313 321 346 374 379 395 383 392 419 408 414 438 435 474 449 463 469
Change (%) 3.89 4.61 18.21 2.77 7.57 8.25 1.26 4.19 -3.07 2.39 6.90 -2.66 1.54 5.73 -0.68 9.11 -5.37 3.22 1.29
% of Revenue 57.81 58.86 59.72 62.17 62.61 63.84 64.47 61.69 60.37 57.40 58.56 62.59 61.25 61.34 64.21 62.99 68.27 64.05 65.94 66.51
SG&A 197 194 197 205 200 199 215 229 243 255 261 261 268 269 271 274 280 294 309 329
Change (%) -1.77 1.93 3.79 -2.30 -0.34 7.89 6.60 5.86 4.87 2.59 -0.06 2.55 0.68 0.44 1.21 2.33 4.93 5.02 6.62
% of Revenue 46.78 45.04 44.53 40.70 38.97 36.81 37.05 37.32 37.11 38.17 39.02 38.99 40.20 39.92 39.70 39.68 40.33 41.96 43.95 46.65
R&D 15 32 15 16 2 35 7 14
Change (%) 112.03 -52.84 -84.90 1,304.59 115.98
% of Revenue 2.28 4.84 2.29 2.41 0.36 5.01 0.95 2.04
OpEx 383 378 384 403 403 452 447 503 550 596 611 601 598 588 588 589 593 603 612 637
Change (%) -1.16 1.43 5.05 -0.03 12.12 -0.97 12.44 9.27 8.44 2.53 -1.64 -0.47 -1.74 0.12 0.14 0.64 1.76 1.51 4.07
% of Revenue 90.85 88.01 86.58 80.09 78.47 83.39 77.04 81.86 84.02 89.36 91.30 89.79 89.85 87.06 86.30 85.35 85.32 86.08 87.15 90.30
Operating Income 39 52 59 100 111 90 133 111 105 71 58 68 68 87 93 101 102 98 90 68
Change (%) 33.64 15.38 68.50 10.34 -18.63 48.19 -16.37 -6.18 -32.16 -17.93 17.33 -1.03 29.18 6.98 8.25 0.86 -4.34 -7.47 -24.19
% of Revenue 9.15 11.99 13.42 19.91 21.53 16.61 22.96 18.14 15.98 10.64 8.70 10.21 10.15 12.94 13.70 14.65 14.68 13.92 12.85 9.70
Interest Expense -25 -26 -27 -28 -28 -32 -35 -37 -39 -40 -39 -34 -28 -20 -14 -14 -15 -17 -18 -19
Change (%) 4.33 3.70 5.89 0.71 11.84 10.31 5.17 6.85 1.57 -1.64 -12.64 -18.61 -27.37 -30.89 0.14 8.72 8.46 7.63 4.55
% of Revenue -5.84 -5.97 -6.01 -5.60 -5.53 -5.86 -6.03 -6.00 -6.02 -5.99 -5.88 -5.13 -4.20 -3.01 -2.06 -2.04 -2.20 -2.36 -2.54 -2.64
Net Income 126 146 148 174 62 42 38 39 21 16 -10 -5 7 42 70 64 -91 -100 -104 -127
Change (%) 15.38 1.52 17.84 -64.60 -31.88 -8.43 2.07 -46.78 -23.81 -165.72 -56.31 -252.87 500.82 67.97 -9.76 -242.67 9.73 4.19 22.88
% of Revenue 29.95 33.87 33.35 34.60 12.01 7.75 6.62 6.39 3.19 2.39 -1.56 -0.68 1.05 6.22 10.34 9.21 -13.06 -14.20 -14.76 -18.06

Source: Capital IQ

Other Listings
DE:82P € 22.60
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista